World

PerkinElmer Unveils Revvity, its Innovative Science-Based Solutions Company for Life Sciences and Diagnostics

 Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Tru...

 May 09, 2023 | News

Biosion shares Anti-CD40 Agonistic Antibody discovery and development data at PEGS

BSI-038 is an anti-CD40 agonistic monoclonal antibody, discovered through Biosion's H³ antibody discovery platform. BSI-038 exhibits enhanced bin...

 May 09, 2023 | News

Ascletis approved for Phase IIa clinical trial of ASC10 for RSV infection in China

--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Do...

 May 09, 2023 | News

Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform

Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...

 May 04, 2023 | News

Clinisys Acquires Promium to Further Grow Scientific, Environmental and Public Health Diagnostics Capabilities

Clinisys  announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated...

 May 04, 2023 | News

Agilent Introduces 8697 Headspace Sampler XL Tray for Smart GC Systems

This new Agilent 8697 -XL Tray also includes the latest instrument intelligence features for increased uptime and operator ease-of-use compared to it...

 May 04, 2023 | News

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy i...

 May 04, 2023 | News

Revolutionizing Drug Development: IQVIA's David Cameron on the Power of Innovative Trial Designs

  Can you tell us about your role as Senior Director & Global Head of Novel Trial Design at IQVIA?  The Novel Trial Design initiative at IQ...

 May 09, 2023 | News

Eppendorf Partners with Clustermarket to Offer Integrated Lab Management Solution

Holistic IoT device and lab management solution With research and development being a time-consuming industry, there is a constant need for time-saving di...

 May 02, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

 May 02, 2023 | News

Medtronic receives FDA approval for its next generation Micra leadless pacing systems

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval ...

 May 02, 2023 | News

Cytiva and the Life Sciences business of Pall have united under the Cytiva name!

Pall Life Sciences and Cytiva have united under the Cytiva name — forming an even stronger global provider of technologies and services that advanc...

 May 02, 2023 | News

Health Canal Survey: Why Older Adults are Hesitant to Receive the Bivalent Booster Shot

The CDC has recommended the bivalent mRNA COVID-19 vaccines since September 2022, yet only 42.4 percent of older adults have received the updated vacc...

 May 02, 2023 | News

FDA Approves Teva and MedinCell's UZEDY™ for Adult Schizophrenia Treatment

This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a ...

 May 01, 2023 | Regulatory


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close